mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
3e-07 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
4e-07 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
5e-07 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
7e-07 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
9e-07 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
9e-07 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.29 |
1e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-06 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-06 |